Found: 194
Select item for more details and to access through your institution.
Identification of novel breast cancer-associated transcripts by uniGene database mining and gene expression analysis in normal and malignant cells.
- Published in:
- Genes, Chromosomes & Cancer, 2013, v. 52, n. 3, p. 316, doi. 10.1002/gcc.22031
- By:
- Publication type:
- Article
Expression of the membrane complement regulatory protein CD59 (protectin) is associated with reduced survival in colorectal cancer patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 8, p. 973, doi. 10.1007/s00262-005-0055-0
- By:
- Publication type:
- Article
The p53 positive Bcl-2 negative phenotype is an independent marker of prognosis in breast cancer.
- Published in:
- International Journal of Cancer, 2007, v. 120, n. 6, p. 1311, doi. 10.1002/ijc.22430
- By:
- Publication type:
- Article
Expression of the stress-related MHC class I chain-related protein MICA is an indicator of good prognosis in colorectal cancer patients.
- Published in:
- International Journal of Cancer, 2006, v. 118, n. 6, p. 1445, doi. 10.1002/ijc.21510
- By:
- Publication type:
- Article
Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis.
- Published in:
- International Journal of Cancer, 2006, v. 118, n. 1, p. 6, doi. 10.1002/ijc.21303
- By:
- Publication type:
- Article
Total loss of MHC class I is an independent indicator of good prognosis in breast cancer.
- Published in:
- International Journal of Cancer, 2005, v. 117, n. 2, p. 248, doi. 10.1002/ijc.21163
- By:
- Publication type:
- Article
High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses.
- Published in:
- International Journal of Cancer, 2005, v. 116, n. 3, p. 340, doi. 10.1002/ijc.21004
- By:
- Publication type:
- Article
High-resolution analysis of 16q22.1 in breast carcinoma using DNA amplifiable probes (multiplex amplifiable probe hybridization technique) and immunohistochemistry.
- Published in:
- International Journal of Cancer, 2005, v. 114, n. 5, p. 720, doi. 10.1002/ijc.20738
- By:
- Publication type:
- Article
Phosphorylation of ERK1/2 mitogen-activated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancer.
- Published in:
- International Journal of Cancer, 2001, v. 95, n. 4, p. 247, doi. 10.1002/1097-0215(20010720)95:4<247::AID-IJC1042>3.0.CO;2-S
- By:
- Publication type:
- Article
Effect of dietary GLA+/−tamoxifen on the growth, ER expression and fatty acid profile of ER positive human breast cancer xenografts.
- Published in:
- International Journal of Cancer, 2001, v. 92, n. 3, p. 342, doi. 10.1002/ijc.1213
- By:
- Publication type:
- Article
Biological and clinical associations of c-jun activation in human breast cancer.
- Published in:
- International Journal of Cancer, 2000, v. 89, n. 2, p. 177, doi. 10.1002/(SICI)1097-0215(20000320)89:2<177::AID-IJC13>3.0.CO;2-0
- By:
- Publication type:
- Article
A possible divergent role for the oestrogen receptor alpha and beta subtypes in clinical breast cancer.
- Published in:
- International Journal of Cancer, 2000, v. 89, n. 2, p. 209, doi. 10.1002/(SICI)1097-0215(20000320)89:2<209::AID-IJC17>3.0.CO;2-6
- By:
- Publication type:
- Article
Gamma linolenic acid with tamoxifen as primary therapy in breast cancer.
- Published in:
- International Journal of Cancer, 2000, v. 85, n. 5, p. 643, doi. 10.1002/(SICI)1097-0215(20000301)85:5<643::AID-IJC8>3.0.CO;2-Z
- By:
- Publication type:
- Article
BRCA1 expression levels predict distant metastasis of sporadic breast cancers.
- Published in:
- International Journal of Cancer, 1999, v. 84, n. 3, p. 258, doi. 10.1002/(SICI)1097-0215(19990621)84:3<258::AID-IJC10>3.0.CO;2-H
- By:
- Publication type:
- Article
Endocrine response and resistance in breast cancer: a role for the transcription factor Fos.
- Published in:
- International Journal of Cancer, 1999, v. 84, n. 1, p. 54, doi. 10.1002/(SICI)1097-0215(19990219)84:1<54::AID-IJC11>3.0.CO;2-X
- By:
- Publication type:
- Article
Correction: Oestrogen receptor negative early operable primary breast cancer in older women—Biological characteristics and long-term clinical outcome.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Oestrogen receptor negative early operable primary breast cancer in older women—Biological characteristics and long-term clinical outcome.
- Published in:
- PLoS ONE, 2017, v. 12, n. 12, p. 1, doi. 10.1371/journal.pone.0188528
- By:
- Publication type:
- Article
5-Carboxylcytosine levels are elevated in human breast cancers and gliomas.
- Published in:
- Clinical Epigenetics, 2015, v. 7, n. 1, p. 1, doi. 10.1186/s13148-015-0117-x
- By:
- Publication type:
- Article
Co-Expression Effect of SLC7A5/SLC3A2 to Predict Response to Endocrine Therapy in Oestrogen-Receptor-Positive Breast Cancer.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 4, p. 1407, doi. 10.3390/ijms21041407
- By:
- Publication type:
- Article
Chromosome 16 tumor‐suppressor genes in breast cancer.
- Published in:
- Genes, Chromosomes & Cancer, 2006, v. 45, n. 6, p. 527, doi. 10.1002/gcc.20318
- By:
- Publication type:
- Article
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer.
- Published in:
- Nature, 2012, v. 481, n. 7381, p. 389, doi. 10.1038/nature10730
- By:
- Publication type:
- Article
Immunocytochemical localization of fos protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy.
- Published in:
- International Journal of Cancer, 1995, v. 64, n. 4, p. 269, doi. 10.1002/ijc.2910640410
- By:
- Publication type:
- Article
Immunocytochemical localization of BCL-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy.
- Published in:
- International Journal of Cancer, 1994, v. 59, n. 5, p. 619, doi. 10.1002/ijc.2910590508
- By:
- Publication type:
- Article
The presentation, management and outcome of patients with ductal carcinoma in situ (DCIS) with microinvasion (invasion ≤1 mm in size)—results from the UK Sloane Project.
- Published in:
- British Journal of Cancer, 2022, v. 127, n. 12, p. 2125, doi. 10.1038/s41416-022-01983-4
- By:
- Publication type:
- Article
Retrospective observational study of HER2 immunohistochemistry in borderline breast cancer patients undergoing neoadjuvant therapy, with an emphasis on Group 2 (HER2/CEP17 ratio ≥2.0, HER2 copy number <4.0 signals/cell) cases.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer.
- Published in:
- Modern Pathology, 2005, v. 18, n. 10, p. 1295, doi. 10.1038/modpathol.3800445
- By:
- Publication type:
- Article
Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis.
- Published in:
- Modern Pathology, 2005, v. 18, n. 1, p. 26, doi. 10.1038/modpathol.3800255
- By:
- Publication type:
- Article
Histologic Grading of Breast Cancer: Linkage of Patient Outcome with Level of Pathologist Agreement.
- Published in:
- Modern Pathology, 2000, v. 13, n. 7, p. 730, doi. 10.1038/modpathol.3880126
- By:
- Publication type:
- Article
SLC1A5 co-expression with TALDO1 associates with endocrine therapy failure in estrogen receptor-positive breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 2, p. 317, doi. 10.1007/s10549-021-06298-1
- By:
- Publication type:
- Article
Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 182, n. 2, p. 267, doi. 10.1007/s10549-020-05670-x
- By:
- Publication type:
- Article
The solute carrier SLC7A8 is a marker of favourable prognosis in ER-positive low proliferative invasive breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 1, p. 1, doi. 10.1007/s10549-020-05586-6
- By:
- Publication type:
- Article
The prognostic significance of wild-type isocitrate dehydrogenase 2 (IDH2) in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 179, n. 1, p. 79, doi. 10.1007/s10549-019-05459-7
- By:
- Publication type:
- Article
CDC20 expression in oestrogen receptor positive breast cancer predicts poor prognosis and lack of response to endocrine therapy.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 178, n. 3, p. 535, doi. 10.1007/s10549-019-05420-8
- By:
- Publication type:
- Article
Utility of ankyrin 3 as a prognostic marker in androgen-receptor-positive breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 176, n. 1, p. 63, doi. 10.1007/s10549-019-05216-w
- By:
- Publication type:
- Article
The combined expression of solute carriers is associated with a poor prognosis in highly proliferative ER+ breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 175, n. 1, p. 27, doi. 10.1007/s10549-018-05111-w
- By:
- Publication type:
- Article
Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 174, n. 2, p. 387, doi. 10.1007/s10549-018-05085-9
- By:
- Publication type:
- Article
Glutamate dehydrogenase (GLUD1) expression in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 174, n. 1, p. 79, doi. 10.1007/s10549-018-5060-z
- By:
- Publication type:
- Article
Connexin 43 is an independent predictor of patient outcome in breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 174, n. 1, p. 93, doi. 10.1007/s10549-018-5063-9
- By:
- Publication type:
- Article
Kinesin family member-18A (KIF18A) is a predictive biomarker of poor benefit from endocrine therapy in early ER+ breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 173, n. 1, p. 93, doi. 10.1007/s10549-018-4978-5
- By:
- Publication type:
- Article
Clinicopathological and prognostic significance of Ras association and pleckstrin homology domains 1 (RAPH1) in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 172, n. 1, p. 61, doi. 10.1007/s10549-018-4891-y
- By:
- Publication type:
- Article
Clinical and biological roles of Kelch-like family member 7 in breast cancer: a marker of poor prognosis.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 170, n. 3, p. 525, doi. 10.1007/s10549-018-4777-z
- By:
- Publication type:
- Article
First international TNBC conference meeting report.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 169, n. 3, p. 407, doi. 10.1007/s10549-018-4692-3
- By:
- Publication type:
- Article
Targeting ataxia telangiectasia-mutated- and Rad3-related kinase (ATR) in PTEN-deficient breast cancers for personalized therapy.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 169, n. 2, p. 277, doi. 10.1007/s10549-018-4683-4
- By:
- Publication type:
- Article
Single-strand selective monofunctional uracil-DNA glycosylase (SMUG1) deficiency is linked to aggressive breast cancer and predicts response to adjuvant therapy.
- Published in:
- Breast Cancer Research & Treatment, 2013, v. 142, n. 3, p. 515, doi. 10.1007/s10549-013-2769-6
- By:
- Publication type:
- Article
Bimodality of intratumor Ki67 expression is an independent prognostic factor of overall survival in patients with invasive breast carcinoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Immune Infiltration in Invasive Lobular Breast Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Therapeutic Targeting of Integrin αvβ6 in Breast Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 8, p. 1, doi. 10.1093/jnci/dju169
- By:
- Publication type:
- Article
Molecular profiling of breast cancer in Nigerian women identifies an altered p53 pathway as a major mechanism underlying its poor prognosis compared with British counterpart.
- Published in:
- Malaysian Journal of Pathology, 2014, v. 36, n. 1, p. 3
- By:
- Publication type:
- Article
Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a retrospective in silico analysis of public datasets.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A whole slide image-based machine learning approach to predict ductal carcinoma in situ (DCIS) recurrence risk.
- Published in:
- 2019
- By:
- Publication type:
- journal article